https://www.prweb.com/releases/andarix_pharmaceuticals_receives_pancreatic_cancer_orphan_drug_designation_from_the_fda/prweb12012733.htm
Andarix Pharmaceuticals Receives Pancreatic Cancer Orphan Drug Designation from the FDA
Somerville, Massachusetts (PRWEB) July 15, 2014 -- ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for cancer...
orphan drug designationpancreatic cancerfrom theandarixpharmaceuticals